|
Volcano CEO to Present at Roth Capital Partners Conference; Webcast Announced
|
 |
 |
|
February 12, 2009,
San Diego -- Volcano Corporation (Nasdaq: VOLC), a leader in the development,
manufacturing and sales of products for the diagnosis and treatment
of coronary and peripheral artery disease, said today that
it will be participating in the Roth Capital Partners 21st
Annual Growth Stock Conference on Wednesday, February 18. |
The presentation by Scott Huennekens, president
and chief executive officer, will begin at 9:30 a.m., Pacific
Standard Time (12:30 p.m., Eastern Standard
Time).
The presentation will be available through
the conference website at http://www.wsw.com/webcast/roth20/volc/ and
via the company's website at http://www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers
a broad suite of devices designed to facilitate endovascular procedures,
enhance the diagnosis of
vascular and structural heart disease and guide optimal therapies.
The company's intravascular ultrasound (IVUS) product line
includes ultrasound consoles that can be integrated directly
into virtually any modern cath lab. Volcano IVUS offers unique
features, including both single-use phased array and rotational
IVUS imaging catheters, and advanced functionality options,
such as VH® IVUS tissue characterization and ChromaFlo®.
Volcano also provides Functional Measurement (FM) consoles
and single-use pressure and flow guide wires and is developing
a line of ultra-high resolution Optical Coherence Tomography
(OCT) systems and catheters. Currently, more than 3,700 Volcano
IVUS and FM systems are installed worldwide, with approximately
half of its revenues coming from outside the United States.
For more information, visit the company's website at http://www.volcanocorp.com.
Source: Volcano Corporation
|
